| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.976 | 0.001 | 0.976 | Vasodilator, peripheral | 0.937 0.002 DBMET03612 0.954 0.002 DBMET03613 0.958 0.002 DBMET03614 | ||
| 0.937 | 0.002 | 0.937 | Antithrombotic | 0.854 0.003 DBMET03612 0.797 0.004 DBMET03613 0.832 0.004 DBMET03614 | ||
| 0.914 | 0.003 | 0.914 | Platelet antagonist | 0.878 0.004 DBMET03612 0.8 0.004 DBMET03613 0.847 0.004 DBMET03614 | ||
| 0.829 | 0.001 | 0.829 | Prostaglandin EP4 antagonist | 0.427 0.002 DBMET03612 0.278 0.003 DBMET03613 0.736 0.001 DBMET03614 | ||
| 0.802 | 0.001 | 0.802 | Prostaglandin EP2 antagonist | 0.765 0.001 DBMET03612 0.725 0.002 DBMET03613 0.772 0.001 DBMET03614 | ||
| 0.794 | 0 | 0.794 | Prostaglandin agonist | 0.661 0.001 DBMET03612 0.597 0.001 DBMET03613 0.677 0 DBMET03614 | ||
| 0.775 | 0 | 0.775 | Prostaglandin E2 agonist | 0.615 0.001 DBMET03612 0.551 0.001 DBMET03613 0.663 0.001 DBMET03614 | ||
| 0.776 | 0.004 | 0.776 | Platelet aggregation inhibitor | 0.664 0.005 DBMET03612 0.582 0.005 DBMET03613 0.616 0.005 DBMET03614 | ||
| 0.766 | 0.005 | 0.766 | Spasmolytic | 0.542 0.019 DBMET03612 0.648 0.009 DBMET03613 0.589 0.014 DBMET03614 | ||
| 0.757 | 0.003 | 0.757 | Prostaglandin antagonist | 0.553 0.004 DBMET03612 0.492 0.004 DBMET03613 0.637 0.003 DBMET03614 | ||
| 0.75 | 0.002 | 0.75 | Prostaglandin E2 antagonist | 0.561 0.003 DBMET03612 0.497 0.003 DBMET03613 0.597 0.003 DBMET03614 | ||
| 0.737 | 0.004 | 0.737 | Vasodilator | 0.669 0.005 DBMET03612 0.638 0.005 DBMET03613 0.672 0.005 DBMET03614 | ||
| 0.701 | 0.005 | 0.752 | Immunosuppressant | 0.727 0.005 DBMET03612 0.752 0.004 DBMET03613 0.721 0.005 DBMET03614 | DBMET03613 | |
| 0.691 | 0 | 0.691 | Thromboxane agonist | 0.254 0 DBMET03612 0.239 0 DBMET03613 0.344 0 DBMET03614 | ||
| 0.689 | 0 | 0.689 | Prostaglandin EP2 agonist | 0.405 0.001 DBMET03612 0.3 0.001 DBMET03613 0.57 0 DBMET03614 | ||
| 0.677 | 0.002 | 0.677 | Gastrin inhibitor | 0.665 0.002 DBMET03612 0.628 0.002 DBMET03613 0.527 0.003 DBMET03614 | ||
| 0.665 | 0.011 | 0.682 | Cholesterol antagonist | 0.571 0.022 DBMET03612 0.599 0.019 DBMET03613 0.682 0.009 DBMET03614 | DBMET03614 | |
| 0.65 | 0.005 | 0.669 | Hypolipemic | 0.389 0.027 DBMET03612 0.441 0.019 DBMET03613 0.669 0.005 DBMET03614 | DBMET03614 | |
| 0.621 | 0.002 | 0.621 | Prostaglandin EP1 antagonist | 0.501 0.003 DBMET03612 0.367 0.003 DBMET03613 0.557 0.002 DBMET03614 | ||
| 0.615 | 0.002 | 0.615 | Gastric antisecretory | 0.413 0.004 DBMET03612 0.37 0.004 DBMET03613 0.441 0.004 DBMET03614 | ||
| 0.602 | 0.001 | 0.61 | Prostaglandin F2 alpha antagonist | 0.474 0.002 DBMET03612 0.49 0.002 DBMET03613 0.61 0.001 DBMET03614 | DBMET03614 | |
| 0.577 | 0.001 | 0.577 | Prostaglandin EP3 antagonist | 0.495 0.002 DBMET03612 0.439 0.002 DBMET03613 0.502 0.002 DBMET03614 | ||
| 0.619 | 0.048 | 0.704 | Antiinflammatory | 0.685 0.034 DBMET03612 0.704 0.03 DBMET03613 0.634 0.045 DBMET03614 | DBMET03613 | |
| 0.592 | 0.037 | 0.653 | Caspase 9 stimulant | 0.652 0.029 DBMET03612 0.653 0.029 DBMET03613 0.593 0.037 DBMET03614 | DBMET03613 | |
| 0.563 | 0.015 | 0.563 | Immunomodulator | 0.509 0.022 DBMET03612 0.458 0.03 DBMET03613 0.548 0.017 DBMET03614 | ||
| 0.55 | 0.004 | 0.55 | Interferon gamma antagonist | 0.457 0.008 DBMET03612 0.459 0.008 DBMET03613 0.525 0.005 DBMET03614 | ||
| 0.539 | 0.001 | 0.539 | Prostaglandin D2 agonist | 0.463 0.001 DBMET03612 0.511 0.001 DBMET03613 0.499 0.001 DBMET03614 | ||
| 0.532 | 0.005 | 0.554 | Interleukin 2 agonist | 0.498 0.008 DBMET03612 0.519 0.006 DBMET03613 0.554 0.004 DBMET03614 | DBMET03614 | |
| 0.529 | 0.005 | 0.529 | Platelet adhesion inhibitor | 0.515 0.005 DBMET03612 0.493 0.005 DBMET03613 0.458 0.007 DBMET03614 | ||
| 0.522 | 0 | 0.522 | Prostaglandin F2 alpha agonist | 0.412 0 DBMET03612 0.296 0 DBMET03613 0.356 0 DBMET03614 | ||
| 0.525 | 0.004 | 0.525 | Hemostatic | 0.261 0.02 DBMET03612 0.22 0.026 DBMET03613 0.342 0.012 DBMET03614 | ||
| 0.537 | 0.024 | 0.61 | Immunostimulant | 0.539 0.024 DBMET03612 0.536 0.024 DBMET03613 0.61 0.015 DBMET03614 | DBMET03614 | |
| 0.511 | 0 | 0.511 | Prostaglandin EP4 agonist | 0.282 0.001 DBMET03612 0.184 0.002 DBMET03613 0.388 0.001 DBMET03614 | ||
| 0.51 | 0.002 | 0.51 | Thromboxane antagonist | 0.29 0.003 DBMET03612 0.212 0.004 DBMET03613 0.398 0.002 DBMET03614 | ||
| 0.507 | 0.005 | 0.507 | Adenylate cyclase inhibitor | 0.309 0.013 DBMET03612 0.217 0.023 DBMET03613 0.292 0.014 DBMET03614 | ||
| 0.491 | 0.009 | 0.584 | Interleukin agonist | 0.375 0.023 DBMET03612 0.41 0.017 DBMET03613 0.584 0.005 DBMET03614 | DBMET03614 | |
| 0.522 | 0.041 | 0.667 | Transcription factor NF kappa B inhibitor | 0.667 0.024 DBMET03612 0.571 0.035 DBMET03613 0.466 0.05 DBMET03614 | DBMET03612 | |
| 0.479 | 0.008 | 0.522 | Hepatoprotectant | 0.522 0.006 DBMET03612 0.452 0.009 DBMET03613 0.393 0.014 DBMET03614 | DBMET03612 | |
| 0.47 | 0.001 | 0.47 | Prostacyclin agonist | 0.33 0.001 DBMET03612 0.25 0.002 DBMET03613 0.343 0.001 DBMET03614 | ||
| 0.454 | 0.002 | 0.454 | Prostacyclin antagonist | 0.275 0.003 DBMET03612 0.129 0.004 DBMET03613 0.174 0.004 DBMET03614 | ||
| 0.418 | 0.007 | 0.418 | Protein kinase stimulant | 0.398 0.008 DBMET03612 0.284 0.019 DBMET03613 0.366 0.01 DBMET03614 | ||
| 0.418 | 0.009 | 0.463 | Bone formation stimulant | 0.312 0.016 DBMET03612 0.442 0.008 DBMET03613 0.463 0.007 DBMET03614 | DBMET03614 | |
| 0.407 | 0.004 | 0.421 | Cholesterol synthesis inhibitor | 0.362 0.006 DBMET03612 0.403 0.004 DBMET03613 0.421 0.004 DBMET03614 | DBMET03614 | |
| 0.454 | 0.055 | 0.481 | Antibacterial | 0.481 0.046 DBMET03612 0.464 0.052 DBMET03613 0.473 0.049 DBMET03614 | DBMET03612 | |
| 0.381 | 0.002 | 0.381 | Thromboxane A2 antagonist | 0.189 0.003 DBMET03612 0.147 0.004 DBMET03613 0.26 0.003 DBMET03614 | ||
| 0.382 | 0.005 | 0.382 | Neurotrophic factor | 0.278 0.009 DBMET03612 0.221 0.019 DBMET03613 0.255 0.011 DBMET03614 | ||
| 0.407 | 0.036 | 0.494 | Apoptosis antagonist | 0.494 0.021 DBMET03612 0.411 0.035 DBMET03613 0.413 0.035 DBMET03614 | DBMET03612 | |
| 0.455 | 0.089 | 0.624 | Apoptosis agonist | 0.624 0.044 DBMET03612 0.501 0.074 DBMET03613 0.452 0.09 DBMET03614 | DBMET03612 | |
| 0.371 | 0.006 | 0.371 | Bronchodilator | 0.327 0.008 DBMET03612 0.228 0.015 DBMET03613 0.244 0.013 DBMET03614 | ||
| 0.426 | 0.077 | 0.492 | Cyclophilin D inhibitor | 0.347 0.124 DBMET03612 0.321 0.145 DBMET03613 0.492 0.053 DBMET03614 | DBMET03614 | |
| 0.368 | 0.029 | 0.386 | Sodium/bile acid cotransporter inhibitor | 0.358 0.035 DBMET03612 0.377 0.025 DBMET03613 0.386 0.021 DBMET03614 | DBMET03614 | |
| 0.374 | 0.04 | 0.508 | Antioxidant | 0.508 0.019 DBMET03612 0.436 0.029 DBMET03613 0.352 0.046 DBMET03614 | DBMET03612 | |
| 0.331 | 0.002 | 0.331 | Adenylate cyclase stimulant | 0.236 0.005 DBMET03612 0.211 0.009 DBMET03613 0.244 0.004 DBMET03614 | ||
| 0.343 | 0.017 | 0.381 | Melanin inhibitor | 0.221 0.034 DBMET03612 0.205 0.039 DBMET03613 0.381 0.013 DBMET03614 | DBMET03614 | |
| 0.375 | 0.051 | 0.665 | 5 Hydroxytryptamine release stimulant | 0.337 0.06 DBMET03612 0.64 0.011 DBMET03613 0.665 0.009 DBMET03614 | DBMET03614 | |
| 0.394 | 0.079 | 0.489 | Histamine release inhibitor | 0.282 0.134 DBMET03612 0.337 0.105 DBMET03613 0.489 0.033 DBMET03614 | DBMET03614 | |
| 0.328 | 0.016 | 0.361 | Phospholipase C inhibitor | 0.298 0.018 DBMET03612 0.25 0.025 DBMET03613 0.361 0.013 DBMET03614 | DBMET03614 | |
| 0.333 | 0.034 | 0.415 | Nitric oxide antagonist | 0.415 0.024 DBMET03612 0.407 0.025 DBMET03613 0.352 0.031 DBMET03614 | DBMET03612 | |
| 0.322 | 0.028 | 0.348 | Growth hormone agonist | 0.305 0.031 DBMET03612 0.331 0.027 DBMET03613 0.348 0.024 DBMET03614 | DBMET03614 | |
| 0.291 | 0 | 0.291 | Thromboxane A2 agonist | 0.128 0.001 DBMET03612 0.095 0.001 DBMET03613 0.161 0.001 DBMET03614 | ||
| 0.276 | 0.004 | 0.276 | Leukotriene antagonist | 0.146 0.011 DBMET03612 0.093 0.025 DBMET03613 0.194 0.006 DBMET03614 | ||
| 0.283 | 0.017 | 0.292 | Antipruritic | 0.264 0.021 DBMET03612 0.187 0.058 DBMET03613 0.292 0.015 DBMET03614 | DBMET03614 | |
| 0.257 | 0.016 | 0.424 | DNA polymerase I inhibitor | 0.424 0.005 DBMET03612 0.325 0.009 DBMET03613 0.234 0.02 DBMET03614 | DBMET03612 | |
| 0.246 | 0.01 | 0.246 | Microtubule formation inhibitor | 0.189 0.023 DBMET03612 0.202 0.019 DBMET03613 0.232 0.013 DBMET03614 | ||
| 0.241 | 0.006 | 0.241 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.146 0.02 DBMET03612 0.086 0.046 DBMET03613 0.1 0.037 DBMET03614 | ||
| 0.307 | 0.075 | 0.433 | Caspase 3 stimulant | 0.309 0.074 DBMET03612 0.433 0.034 DBMET03613 0.429 0.036 DBMET03614 | DBMET03613 | |
| 0.234 | 0.003 | 0.234 | Leukotriene B4 antagonist | 0.159 0.005 DBMET03612 0.078 0.016 DBMET03613 0.173 0.004 DBMET03614 | ||
| 0.284 | 0.055 | 0.347 | Angiogenesis stimulant | 0.278 0.058 DBMET03612 0.288 0.054 DBMET03613 0.347 0.033 DBMET03614 | DBMET03614 | |
| 0.248 | 0.023 | 0.26 | Succinate dehydrogenase inhibitor | 0.233 0.029 DBMET03612 0.243 0.025 DBMET03613 0.26 0.019 DBMET03614 | DBMET03614 | |
| 0.248 | 0.027 | 0.248 | NOS3 expression enhancer | 0.189 0.045 DBMET03612 0.129 0.099 DBMET03613 0.173 0.054 DBMET03614 | ||
| 0.232 | 0.016 | 0.257 | Interleukin 4 antagonist | 0.217 0.018 DBMET03612 0.24 0.014 DBMET03613 0.257 0.012 DBMET03614 | DBMET03614 | |
| 0.233 | 0.018 | 0.233 | ATPase inhibitor | 0.224 0.022 DBMET03612 0.163 0.08 DBMET03613 0.204 0.034 DBMET03614 | ||
| 0.272 | 0.064 | 0.38 | Hypoglycemic | 0.255 0.074 DBMET03612 0.267 0.067 DBMET03613 0.38 0.031 DBMET03614 | DBMET03614 | |
| 0.242 | 0.036 | 0.316 | Lipocortins synthesis antagonist | 0.285 0.024 DBMET03612 0.316 0.018 DBMET03613 0.272 0.027 DBMET03614 | DBMET03613 | |
| 0.222 | 0.016 | 0.242 | Arachidonic acid antagonist | 0.233 0.01 DBMET03612 0.242 0.007 DBMET03613 0.231 0.011 DBMET03614 | DBMET03613 | |
| 0.264 | 0.058 | 0.302 | DNA synthesis inhibitor | 0.253 0.065 DBMET03612 0.29 0.047 DBMET03613 0.302 0.043 DBMET03614 | DBMET03614 | |
| 0.272 | 0.068 | 0.404 | Transcription factor STAT3 inhibitor | 0.404 0.018 DBMET03612 0.176 0.17 DBMET03614 | DBMET03612 | |
| 0.225 | 0.024 | 0.225 | Hexokinase inhibitor | 0.14 0.091 DBMET03612 0.141 0.09 DBMET03613 0.162 0.065 DBMET03614 | ||
| 0.233 | 0.045 | 0.308 | Insulin sensitizer | 0.187 0.088 DBMET03612 0.197 0.077 DBMET03613 0.308 0.014 DBMET03614 | DBMET03614 | |
| 0.199 | 0.011 | 0.263 | Phosphofructokinase-1 inhibitor | 0.218 0.009 DBMET03612 0.263 0.007 DBMET03613 0.242 0.008 DBMET03614 | DBMET03613 | |
| 0.234 | 0.05 | 0.307 | Non-steroidal antiinflammatory agent | 0.147 0.118 DBMET03612 0.254 0.041 DBMET03613 0.307 0.027 DBMET03614 | DBMET03614 | |
| 0.284 | 0.101 | 0.308 | Vasodilator, coronary | 0.308 0.081 DBMET03614 | DBMET03614 | |
| 0.184 | 0.006 | 0.2 | Anabolic | 0.182 0.007 DBMET03612 0.2 0.004 DBMET03613 0.184 0.006 DBMET03614 | DBMET03613 | |
| 0.211 | 0.037 | 0.387 | Phospholipase A2 inhibitor | 0.309 0.012 DBMET03612 0.387 0.005 DBMET03613 0.301 0.013 DBMET03614 | DBMET03613 | |
| 0.189 | 0.017 | 0.238 | Adenylate kinase inhibitor | 0.185 0.017 DBMET03612 0.233 0.011 DBMET03613 0.238 0.011 DBMET03614 | DBMET03614 | |
| 0.262 | 0.092 | 0.385 | Lipoxygenase inhibitor | 0.385 0.041 DBMET03612 0.302 0.07 DBMET03613 | DBMET03612 | |
| 0.193 | 0.027 | 0.232 | Toll-Like receptor 2 antagonist | 0.129 0.069 DBMET03612 0.144 0.057 DBMET03613 0.232 0.013 DBMET03614 | DBMET03614 | |
| 0.23 | 0.067 | 0.231 | Peptidyltransferase inhibitor | 0.216 0.08 DBMET03612 0.216 0.08 DBMET03613 0.231 0.066 DBMET03614 | DBMET03614 | |
| 0.281 | 0.123 | 0.335 | Toll-Like receptor agonist | 0.221 0.178 DBMET03613 0.335 0.09 DBMET03614 | DBMET03614 | |
| 0.169 | 0.013 | 0.28 | Electron transport complex I inhibitor | 0.155 0.018 DBMET03612 0.28 0.005 DBMET03613 0.226 0.006 DBMET03614 | DBMET03613 | |
| 0.162 | 0.009 | 0.284 | T cell inhibitor | 0.153 0.01 DBMET03612 0.284 0.005 DBMET03613 0.211 0.007 DBMET03614 | DBMET03613 | |
| 0.252 | 0.099 | 0.252 | Hypoxia-inducible factor 1 alpha inhibitor | 0.224 0.125 DBMET03612 | ||
| 0.171 | 0.021 | 0.314 | Photosensitizer | 0.283 0.005 DBMET03612 0.314 0.004 DBMET03613 0.19 0.015 DBMET03614 | DBMET03613 | |
| 0.171 | 0.023 | 0.246 | Vanilloid 1 agonist | 0.236 0.006 DBMET03612 0.246 0.005 DBMET03613 0.195 0.013 DBMET03614 | DBMET03613 | |
| 0.162 | 0.015 | 0.162 | ABCA1 expression enhancer | 0.113 0.036 DBMET03612 | ||
| 0.164 | 0.019 | 0.174 | Ca2+-transporting ATPase inhibitor | 0.168 0.014 DBMET03612 0.174 0.01 DBMET03613 0.169 0.013 DBMET03614 | DBMET03613 | |
| 0.16 | 0.016 | 0.186 | Toll-Like receptor 4 antagonist | 0.17 0.012 DBMET03612 0.186 0.009 DBMET03613 0.167 0.014 DBMET03614 | DBMET03613 | |
| 0.15 | 0.011 | 0.159 | Interleukin 5 antagonist | 0.15 0.011 DBMET03612 0.159 0.009 DBMET03613 0.159 0.009 DBMET03614 | DBMET03614 | |
| 0.16 | 0.024 | 0.207 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.161 0.024 DBMET03612 0.207 0.015 DBMET03613 0.206 0.015 DBMET03614 | DBMET03613 | |
| 0.207 | 0.071 | 0.275 | Anesthetic general | 0.227 0.061 DBMET03612 0.275 0.04 DBMET03613 0.257 0.047 DBMET03614 | DBMET03613 | |
| 0.177 | 0.042 | 0.272 | Alpha-N-acetylglucosaminidase inhibitor | 0.126 0.072 DBMET03612 0.195 0.035 DBMET03613 0.272 0.019 DBMET03614 | DBMET03614 | |
| 0.19 | 0.057 | 0.236 | Thrombolytic | 0.236 0.037 DBMET03612 0.163 0.073 DBMET03613 0.173 0.066 DBMET03614 | DBMET03612 | |
| 0.209 | 0.079 | 0.268 | Interleukin antagonist | 0.268 0.055 DBMET03612 0.231 0.069 DBMET03613 0.265 0.056 DBMET03614 | DBMET03612 | |
| 0.176 | 0.051 | 0.176 | Insulin secretagoues | 0.168 0.057 DBMET03614 | ||
| 0.146 | 0.021 | 0.211 | Triose-phosphate isomerase inhibitor | 0.135 0.025 DBMET03612 0.194 0.012 DBMET03613 0.211 0.01 DBMET03614 | DBMET03614 | |
| 0.134 | 0.012 | 0.134 | ATPase (Vacuolar H+) inhibitor | 0.133 0.013 DBMET03612 0.122 0.019 DBMET03613 0.134 0.012 DBMET03614 | ||
| 0.132 | 0.011 | 0.132 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 DBMET03612 0.114 0.02 DBMET03613 0.126 0.013 DBMET03614 | ||
| 0.153 | 0.033 | 0.206 | GABA C receptor agonist | 0.175 0.026 DBMET03612 0.206 0.019 DBMET03613 0.18 0.025 DBMET03614 | DBMET03613 | |
| 0.153 | 0.034 | 0.188 | Expectorant | 0.099 0.07 DBMET03613 0.188 0.023 DBMET03614 | DBMET03614 | |
| 0.147 | 0.031 | 0.159 | Antineoplastic antibiotic | 0.132 0.035 DBMET03612 0.142 0.033 DBMET03613 0.159 0.029 DBMET03614 | DBMET03614 | |
| 0.119 | 0.004 | 0.119 | Nitric oxide donor | 0.105 0.006 DBMET03612 0.105 0.006 DBMET03613 0.119 0.004 DBMET03614 | ||
| 0.225 | 0.11 | 0.316 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 DBMET03612 0.316 0.037 DBMET03613 0.289 0.051 DBMET03614 | DBMET03613 | |
| 0.187 | 0.074 | 0.23 | P-glycoprotein inhibitor | 0.226 0.05 DBMET03612 0.23 0.049 DBMET03614 | DBMET03614 | |
| 0.145 | 0.035 | 0.148 | Mucolytic | 0.116 0.058 DBMET03613 0.148 0.033 DBMET03614 | DBMET03614 | |
| 0.128 | 0.02 | 0.17 | Ornithine decarboxylase inhibitor | 0.17 0.007 DBMET03612 0.125 0.022 DBMET03613 0.11 0.034 DBMET03614 | DBMET03612 | |
| 0.11 | 0.003 | 0.217 | ATP citrate lysase inhibitor | 0.08 0.004 DBMET03612 0.16 0.003 DBMET03613 0.217 0.002 DBMET03614 | DBMET03614 | |
| 0.202 | 0.096 | 0.446 | Free radical scavenger | 0.446 0.022 DBMET03612 0.326 0.045 DBMET03613 0.197 0.1 DBMET03614 | DBMET03612 | |
| 0.286 | 0.181 | 0.382 | 5 Hydroxytryptamine release inhibitor | 0.328 0.136 DBMET03613 0.382 0.09 DBMET03614 | DBMET03614 | |
| 0.109 | 0.005 | 0.109 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET03612 0.058 0.03 DBMET03613 0.058 0.031 DBMET03614 | ||
| 0.106 | 0.006 | 0.106 | Sphingosine kinase inhibitor | 0.075 0.02 DBMET03612 0.093 0.01 DBMET03613 0.106 0.006 DBMET03614 | ||
| 0.146 | 0.048 | 0.275 | Monophenol monooxygenase inhibitor | 0.275 0.021 DBMET03612 0.227 0.027 DBMET03613 0.158 0.044 DBMET03614 | DBMET03612 | |
| 0.203 | 0.107 | 0.296 | Tumour necrosis factor alpha release inhibitor | 0.232 0.084 DBMET03612 0.291 0.057 DBMET03613 0.296 0.055 DBMET03614 | DBMET03614 | |
| 0.114 | 0.02 | 0.164 | Interferon agonist | 0.082 0.049 DBMET03612 0.108 0.023 DBMET03613 0.164 0.009 DBMET03614 | DBMET03614 | |
| 0.098 | 0.005 | 0.123 | Glucose-6-phosphate isomerase inhibitor | 0.107 0.004 DBMET03612 0.123 0.003 DBMET03613 0.113 0.004 DBMET03614 | DBMET03613 | |
| 0.094 | 0.002 | 0.096 | HMG CoA reductase inhibitor | 0.051 0.007 DBMET03612 0.052 0.006 DBMET03613 0.096 0.002 DBMET03614 | DBMET03614 | |
| 0.111 | 0.02 | 0.148 | Leukotriene synthesis inhibitor | 0.104 0.024 DBMET03612 0.148 0.009 DBMET03613 0.129 0.014 DBMET03614 | DBMET03613 | |
| 0.243 | 0.153 | 0.283 | Toll-Like receptor 7 agonist | 0.283 0.121 DBMET03614 | DBMET03614 | |
| 0.113 | 0.025 | 0.168 | Glutamate dehydrogenase inhibitor | 0.134 0.019 DBMET03612 0.168 0.013 DBMET03613 0.143 0.017 DBMET03614 | DBMET03613 | |
| 0.109 | 0.023 | 0.116 | CDC25A inhibitor | 0.096 0.03 DBMET03612 0.102 0.027 DBMET03613 0.116 0.02 DBMET03614 | DBMET03614 | |
| 0.209 | 0.126 | 0.359 | Transcription factor STAT inhibitor | 0.359 0.031 DBMET03612 | DBMET03612 | |
| 0.108 | 0.026 | 0.344 | Vanilloid agonist | 0.145 0.011 DBMET03612 0.344 0.004 DBMET03613 0.119 0.019 DBMET03614 | DBMET03613 | |
| 0.12 | 0.039 | 0.12 | Folate antagonist | 0.096 0.073 DBMET03613 0.104 0.058 DBMET03614 | ||
| 0.129 | 0.049 | 0.204 | TRPA1 agonist | 0.171 0.019 DBMET03612 0.204 0.01 DBMET03613 0.155 0.028 DBMET03614 | DBMET03613 | |
| 0.084 | 0.004 | 0.084 | Leukotriene B4 receptor 1 antagonist | 0.043 0.01 DBMET03612 0.032 0.017 DBMET03613 0.056 0.005 DBMET03614 | ||
| 0.094 | 0.015 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.085 0.017 DBMET03612 0.087 0.017 DBMET03613 0.091 0.016 DBMET03614 | ||
| 0.096 | 0.02 | 0.097 | Vanilloid 4 agonist | 0.072 0.057 DBMET03612 0.086 0.031 DBMET03613 0.097 0.019 DBMET03614 | DBMET03614 | |
| 0.101 | 0.027 | 0.101 | Peroxisome proliferator-activated receptor gamma agonist | 0.083 0.038 DBMET03612 0.083 0.039 DBMET03613 0.096 0.03 DBMET03614 | ||
| 0.092 | 0.018 | 0.159 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 DBMET03612 0.14 0.01 DBMET03613 0.159 0.008 DBMET03614 | DBMET03614 | |
| 0.131 | 0.058 | 0.131 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET03614 | ||
| 0.092 | 0.019 | 0.092 | Neuraminidase inhibitor | 0.06 0.043 DBMET03612 0.069 0.034 DBMET03614 | ||
| 0.104 | 0.032 | 0.104 | Hematopoietic | 0.08 0.073 DBMET03612 0.088 0.053 DBMET03614 | ||
| 0.071 | 0.004 | 0.071 | Leukotriene B4 receptor 2 antagonist | 0.028 0.009 DBMET03612 0.042 0.005 DBMET03614 | ||
| 0.09 | 0.024 | 0.157 | Carbamoyl phosphate synthetase inhibitor | 0.107 0.019 DBMET03612 0.157 0.01 DBMET03613 0.134 0.013 DBMET03614 | DBMET03613 | |
| 0.086 | 0.022 | 0.086 | Neuraminidase (influenza) inhibitor | 0.064 0.046 DBMET03614 | ||
| 0.084 | 0.021 | 0.111 | Interferon inducer | 0.076 0.028 DBMET03613 0.111 0.009 DBMET03614 | DBMET03614 | |
| 0.076 | 0.016 | 0.086 | Aconitate hydratase inhibitor | 0.071 0.018 DBMET03612 0.081 0.013 DBMET03613 0.086 0.012 DBMET03614 | DBMET03614 | |
| 0.198 | 0.14 | 0.237 | Tyrosine 3 hydroxylase inhibitor | 0.213 0.114 DBMET03612 0.237 0.082 DBMET03613 0.221 0.102 DBMET03614 | DBMET03613 | |
| 0.08 | 0.024 | 0.11 | Glutamate (mGluR6) antagonist | 0.086 0.018 DBMET03612 0.11 0.008 DBMET03613 0.101 0.01 DBMET03614 | DBMET03613 | |
| 0.069 | 0.015 | 0.088 | Leukotriene C antagonist | 0.088 0.005 DBMET03612 0.07 0.014 DBMET03613 0.075 0.01 DBMET03614 | DBMET03612 | |
| 0.132 | 0.078 | 0.18 | Farnesoid X receptor antagonist | 0.164 0.039 DBMET03612 0.18 0.029 DBMET03613 0.142 0.062 DBMET03614 | DBMET03613 | |
| 0.062 | 0.009 | 0.063 | Sphingosine kinase 1 inhibitor | 0.043 0.026 DBMET03612 0.055 0.012 DBMET03613 0.063 0.008 DBMET03614 | DBMET03614 | |
| 0.055 | 0.002 | 0.055 | Vitamin D receptor agonist | 0.05 0.003 DBMET03612 0.027 0.004 DBMET03613 0.053 0.002 DBMET03614 | ||
| 0.103 | 0.052 | 0.117 | Prolactin inhibitor | 0.097 0.058 DBMET03612 0.111 0.045 DBMET03613 0.117 0.041 DBMET03614 | DBMET03614 | |
| 0.083 | 0.035 | 0.106 | Glycine receptor agonist | 0.092 0.026 DBMET03612 0.106 0.018 DBMET03613 0.095 0.024 DBMET03614 | DBMET03613 | |
| 0.058 | 0.011 | 0.058 | Membrane dipeptidase inhibitor | 0.058 0.011 DBMET03612 0.056 0.012 DBMET03613 0.056 0.012 DBMET03614 | ||
| 0.068 | 0.023 | 0.076 | Lipocortins synthesis agonist | 0.072 0.02 DBMET03612 0.076 0.017 DBMET03613 0.072 0.02 DBMET03614 | DBMET03613 | |
| 0.068 | 0.023 | 0.068 | Peroxisome proliferator-activated receptor alpha agonist | 0.063 0.025 DBMET03614 | ||
| 0.118 | 0.073 | 0.175 | Aldehyde dehydrogenase inhibitor | 0.175 0.035 DBMET03612 0.154 0.045 DBMET03613 0.143 0.052 DBMET03614 | DBMET03612 | |
| 0.053 | 0.012 | 0.072 | Fumarate hydratase inhibitor | 0.062 0.01 DBMET03612 0.072 0.008 DBMET03613 0.061 0.01 DBMET03614 | DBMET03613 | |
| 0.083 | 0.043 | 0.083 | GABA aminotransferase inhibitor | 0.068 0.065 DBMET03614 | ||
| 0.082 | 0.043 | 0.127 | Glutamate decarboxylase inhibitor | 0.099 0.03 DBMET03612 0.127 0.018 DBMET03613 0.105 0.027 DBMET03614 | DBMET03613 | |
| 0.069 | 0.031 | 0.176 | Argininosuccinate synthase inhibitor | 0.109 0.017 DBMET03612 0.176 0.009 DBMET03613 0.116 0.016 DBMET03614 | DBMET03613 | |
| 0.088 | 0.054 | 0.099 | Transcription factor NF kappa B stimulant | 0.098 0.041 DBMET03612 0.099 0.039 DBMET03613 0.088 0.053 DBMET03614 | DBMET03613 | |
| 0.055 | 0.021 | 0.1 | Mannosidase inhibitor | 0.052 0.023 DBMET03613 0.1 0.006 DBMET03614 | DBMET03614 | |
| 0.041 | 0.009 | 0.074 | Calcium-independent phospholipase A2 inhibitor | 0.063 0.003 DBMET03612 0.074 0.002 DBMET03613 0.042 0.008 DBMET03614 | DBMET03613 | |
| 0.083 | 0.052 | 0.108 | Glycine receptor antagonist | 0.093 0.039 DBMET03612 0.108 0.025 DBMET03613 0.097 0.035 DBMET03614 | DBMET03613 | |
| 0.045 | 0.015 | 0.063 | Leukotriene C4 antagonist | 0.063 0.005 DBMET03612 0.047 0.013 DBMET03613 0.05 0.01 DBMET03614 | DBMET03612 | |
| 0.046 | 0.017 | 0.066 | Arginase inhibitor | 0.037 0.025 DBMET03612 0.056 0.012 DBMET03613 0.066 0.008 DBMET03614 | DBMET03614 | |
| 0.095 | 0.066 | 0.097 | Sphingomyelinase inhibitor | 0.097 0.063 DBMET03614 | DBMET03614 | |
| 0.054 | 0.027 | 0.069 | Adenosine deaminase inhibitor | 0.043 0.037 DBMET03613 0.069 0.014 DBMET03614 | DBMET03614 | |
| 0.05 | 0.024 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.017 DBMET03614 | DBMET03614 | |
| 0.051 | 0.027 | 0.051 | Microtubule stabilization | 0.043 0.037 DBMET03612 0.046 0.033 DBMET03613 0.05 0.028 DBMET03614 | ||
| 0.044 | 0.022 | 0.048 | Kainate receptor agonist | 0.048 0.016 DBMET03612 0.047 0.018 DBMET03613 0.043 0.024 DBMET03614 | DBMET03612 | |
| 0.074 | 0.052 | 0.088 | Catalase inhibitor | 0.07 0.054 DBMET03612 0.084 0.045 DBMET03613 0.088 0.043 DBMET03614 | DBMET03614 | |
| 0.039 | 0.018 | 0.046 | Glutamate (mGluR8) antagonist | 0.041 0.016 DBMET03612 0.046 0.011 DBMET03613 0.044 0.012 DBMET03614 | DBMET03613 | |
| 0.055 | 0.034 | 0.061 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.044 DBMET03612 0.056 0.032 DBMET03613 0.061 0.024 DBMET03614 | DBMET03614 | |
| 0.091 | 0.071 | 0.12 | Bile acid receptor antagonist | 0.111 0.03 DBMET03612 0.12 0.02 DBMET03613 0.101 0.048 DBMET03614 | DBMET03613 | |
| 0.057 | 0.038 | 0.062 | Pregnane X receptor antagonist | 0.062 0.027 DBMET03612 0.06 0.031 DBMET03613 0.056 0.043 DBMET03614 | DBMET03612 | |
| 0.027 | 0.009 | 0.028 | Vitamin D receptor antagonist | 0.028 0.008 DBMET03612 0.028 0.008 DBMET03613 0.026 0.009 DBMET03614 | DBMET03613 | |
| 0.021 | 0.003 | 0.022 | Calcineurin inhibitor | 0.021 0.003 DBMET03612 0.022 0.003 DBMET03613 0.022 0.003 DBMET03614 | DBMET03614 | |
| 0.025 | 0.008 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET03614 | DBMET03614 | |
| 0.055 | 0.04 | 0.155 | Alcohol oxidase inhibitor | 0.064 0.033 DBMET03613 0.155 0.01 DBMET03614 | DBMET03614 | |
| 0.028 | 0.014 | 0.035 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET03613 0.035 0.007 DBMET03614 | DBMET03614 | |
| 0.035 | 0.02 | 0.061 | Squalene synthetase inhibitor | 0.033 0.022 DBMET03612 0.061 0.011 DBMET03613 0.05 0.014 DBMET03614 | DBMET03613 | |
| 0.061 | 0.049 | 0.071 | Selectin antagonist | 0.071 0.042 DBMET03614 | DBMET03614 | |
| 0.026 | 0.016 | 0.035 | Vanilloid 2 agonist | 0.028 0.013 DBMET03612 0.035 0.005 DBMET03613 0.032 0.007 DBMET03614 | DBMET03613 | |
| 0.025 | 0.017 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.022 DBMET03613 0.028 0.013 DBMET03614 | DBMET03614 | |
| 0.05 | 0.043 | 0.068 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET03613 0.068 0.018 DBMET03614 | DBMET03614 | |
| 0.028 | 0.022 | 0.035 | RNA-directed RNA polymerase stimulant | 0.029 0.021 DBMET03612 0.035 0.018 DBMET03613 0.033 0.019 DBMET03614 | DBMET03613 | |
| 0.022 | 0.018 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET03613 0.024 0.013 DBMET03614 | DBMET03614 | |
| 0.091 | 0.088 | 0.091 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.035 | 0.034 | 0.048 | Toll-Like receptor 2 agonist | 0.048 0.024 DBMET03614 | DBMET03614 | |
| 0.068 | 0.069 | 0.083 | Keratolytic | 0.083 0.045 DBMET03612 0.082 0.046 DBMET03613 | DBMET03612 | |
| 0.011 | 0.012 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET03614 | DBMET03614 | |
| 0.04 | 0.041 | 0.074 | Antimetabolite | 0.043 0.037 DBMET03612 0.074 0.02 DBMET03613 0.053 0.03 DBMET03614 | DBMET03613 | |
| 0.044 | 0.046 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET03614 | DBMET03614 | |
| 0.145 | 0.146 | 0.184 | Neurotrophic factor enhancer | 0.15 0.138 DBMET03612 0.184 0.093 DBMET03613 0.179 0.099 DBMET03614 | DBMET03613 | |
| 0.062 | 0.065 | 0.086 | Aminopeptidase I inhibitor | 0.079 0.043 DBMET03613 0.086 0.037 DBMET03614 | DBMET03614 | |
| 0.026 | 0.029 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET03614 | DBMET03614 | |
| 0.043 | 0.048 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 DBMET03613 0.06 0.032 DBMET03614 | DBMET03614 | |
| 0.024 | 0.031 | 0.036 | Hedgehog signaling activator | 0.029 0.016 DBMET03613 0.036 0.006 DBMET03614 | DBMET03614 | |
| 0.019 | 0.025 | 0.034 | Prostaglandin H2 antagonist | 0.025 0.018 DBMET03613 0.034 0.009 DBMET03614 | DBMET03614 | |
| 0.016 | 0.023 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.012 DBMET03614 | DBMET03614 | |
| 0.03 | 0.038 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.032 DBMET03614 | DBMET03614 | |
| 0.009 | 0.019 | 0.09 | Calcium-dependent phospholipase A2 inhibitor | 0.037 0.004 DBMET03612 0.09 0.003 DBMET03613 | DBMET03613 | |
| 0.011 | 0.022 | 0.022 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET03613 0.022 0.008 DBMET03614 | DBMET03614 | |
| 0.039 | 0.05 | 0.08 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 DBMET03612 0.08 0.025 DBMET03613 0.056 0.037 DBMET03614 | DBMET03613 | |
| 0.039 | 0.051 | 0.081 | Ribonucleotide reductase inhibitor | 0.081 0.026 DBMET03613 0.057 0.038 DBMET03614 | DBMET03613 | |
| 0.075 | 0.088 | 0.119 | Aminopeptidase B inhibitor | 0.115 0.055 DBMET03613 0.119 0.053 DBMET03614 | DBMET03614 | |
| 0.045 | 0.061 | 0.055 | Biliverdin reductase inhibitor | 0.055 0.046 DBMET03614 | DBMET03614 | |
| 0.098 | 0.119 | 0.17 | Lipid peroxidase inhibitor | 0.138 0.077 DBMET03612 0.17 0.055 DBMET03613 0.145 0.072 DBMET03614 | DBMET03613 | |
| 0.023 | 0.047 | 0.098 | 5-Alpha-reductase inhibitor | 0.033 0.03 DBMET03612 0.098 0.01 DBMET03613 0.048 0.02 DBMET03614 | DBMET03613 | |
| 0.073 | 0.1 | 0.152 | Thioredoxin inhibitor | 0.152 0.016 DBMET03612 0.12 0.031 DBMET03613 | DBMET03612 | |
| 0.034 | 0.066 | 0.063 | Plasminogen activator inhibitor antagonist | 0.063 0.022 DBMET03612 | DBMET03612 | |
| 0.025 | 0.058 | 0.043 | Glutamate (mGluR3) antagonist | 0.043 0.017 DBMET03613 0.04 0.02 DBMET03614 | DBMET03613 | |
| 0.042 | 0.076 | 0.05 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET03613 | DBMET03613 | |
| 0.075 | 0.112 | 0.093 | Electrolyte absorption antagonist | 0.093 0.069 DBMET03614 | DBMET03614 | |
| 0.115 | 0.153 | 0.236 | Psychostimulant | 0.163 0.105 DBMET03612 0.236 0.064 DBMET03613 0.171 0.099 DBMET03614 | DBMET03613 | |
| 0.089 | 0.127 | 0.106 | Estrogen antagonist | 0.106 0.084 DBMET03612 0.105 0.085 DBMET03613 | DBMET03612 | |
| 0.028 | 0.066 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.029 DBMET03613 | DBMET03613 | |
| 0.048 | 0.087 | 0.065 | Caspase 9 inhibitor | 0.061 0.045 DBMET03612 0.065 0.039 DBMET03613 | DBMET03613 | |
| 0.005 | 0.046 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 DBMET03614 | DBMET03614 | |
| 0.024 | 0.064 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.021 DBMET03613 0.03 0.028 DBMET03614 | DBMET03613 | |
| 0.04 | 0.083 | 0.058 | Vanilloid 2 antagonist | 0.058 0.025 DBMET03614 | DBMET03614 | |
| 0.026 | 0.07 | 0.045 | HIV-1 protease inhibitor | 0.045 0.028 DBMET03614 | DBMET03614 | |
| 0.024 | 0.069 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.036 0.027 DBMET03612 0.037 0.024 DBMET03613 0.035 0.029 DBMET03614 | DBMET03613 | |
| 0.07 | 0.117 | 0.142 | Lanosterol 14 alpha demethylase inhibitor | 0.106 0.047 DBMET03612 0.142 0.014 DBMET03613 | DBMET03613 | |
| 0.04 | 0.092 | 0.108 | HIV-1 integrase (3'-Processing) inhibitor | 0.108 0.023 DBMET03612 | DBMET03612 | |
| 0.06 | 0.114 | 0.089 | 5-Lipoxygenase inhibitor | 0.089 0.073 DBMET03612 | DBMET03612 | |
| 0.042 | 0.096 | 0.057 | Cathepsin E inhibitor | 0.057 0.046 DBMET03614 | DBMET03614 | |
| 0.033 | 0.088 | 0.146 | HIV-1 integrase (Strand Transfer) inhibitor | 0.146 0.013 DBMET03612 0.091 0.026 DBMET03613 | DBMET03612 | |
| 0.024 | 0.079 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.033 DBMET03614 | DBMET03614 | |
| 0.061 | 0.118 | 0.089 | Protease inhibitor | 0.089 0.075 DBMET03614 | DBMET03614 | |
| 0.072 | 0.136 | 0.093 | GABA C receptor antagonist | 0.093 0.09 DBMET03614 | DBMET03614 | |
| 0.079 | 0.146 | 0.103 | Cyclooxygenase 3 inhibitor | 0.103 0.099 DBMET03614 | DBMET03614 | |
| 0.041 | 0.109 | 0.067 | Elastase 1 inhibitor | 0.067 0.05 DBMET03612 0.066 0.052 DBMET03613 | DBMET03612 | |
| 0.062 | 0.131 | 0.082 | NADH dehydrogenase inhibitor | 0.082 0.071 DBMET03614 | DBMET03614 | |
| 0.107 | 0.18 | 0.142 | Interleukin 6 antagonist | 0.142 0.102 DBMET03614 | DBMET03614 | |
| 0.057 | 0.132 | 0.108 | Alcohol dehydrogenase inhibitor | 0.085 0.072 DBMET03613 0.108 0.044 DBMET03614 | DBMET03614 | |
| 0.056 | 0.132 | 0.087 | Mediator release inhibitor | 0.087 0.085 DBMET03612 | DBMET03612 | |
| 0.055 | 0.131 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.066 DBMET03613 | DBMET03613 | |
| 0.14 | 0.226 | 0.171 | RNA-directed DNA polymerase inhibitor | 0.169 0.155 DBMET03613 0.171 0.15 DBMET03614 | DBMET03614 | |
| 0.049 | 0.138 | 0.084 | Carbonic anhydrase VI inhibitor | 0.084 0.052 DBMET03612 | DBMET03612 | |
| 0.013 | 0.11 | 0.059 | Estrogen agonist | 0.059 0.03 DBMET03613 | DBMET03613 | |
| 0.034 | 0.133 | 0.122 | Porphobilinogen synthase inhibitor | 0.082 0.046 DBMET03612 0.122 0.028 DBMET03613 | DBMET03613 | |
| 0.026 | 0.129 | 0.059 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET03613 0.059 0.018 DBMET03614 | DBMET03614 | |
| 0.016 | 0.122 | 0.068 | Macrophage elastase inhibitor | 0.068 0.015 DBMET03614 | DBMET03614 | |
| 0.004 | 0.114 | 0.08 | Estrogen receptor alpha agonist | 0.08 0.012 DBMET03613 | DBMET03613 | |
| 0.028 | 0.138 | 0.071 | Androgen agonist | 0.071 0.029 DBMET03613 | DBMET03613 | |
| 0.029 | 0.142 | 0.134 | Glucose-6-phosphate translocase inhibitor | 0.134 0.004 DBMET03612 | DBMET03612 | |
| 0.026 | 0.147 | 0.051 | HCV NS3/NS4A protease inhibitor | 0.046 0.039 DBMET03612 0.051 0.03 DBMET03613 | DBMET03613 | |
| 0.078 | 0.203 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.062 DBMET03612 | DBMET03612 | |
| 0.093 | 0.222 | 0.164 | Aldehyde oxidase inhibitor | 0.164 0.127 DBMET03614 | DBMET03614 | |
| 0.055 | 0.198 | 0.078 | Thioredoxin reductase inhibitor | 0.078 0.067 DBMET03612 | DBMET03612 | |
| 0.031 | 0.178 | 0.07 | Sirtuin 1 inhibitor | 0.07 0.045 DBMET03612 | DBMET03612 | |
| 0.113 | 0.262 | 0.19 | Superoxide dismutase inhibitor | 0.19 0.129 DBMET03612 | DBMET03612 | |
| 0.115 | 0.266 | 0.179 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.179 0.094 DBMET03613 | DBMET03613 | |
| 0.007 | 0.166 | 0.034 | Histone deacetylase 10 inhibitor | 0.034 0.018 DBMET03613 | DBMET03613 | |
| 0.027 | 0.199 | 0.159 | Transcription factor AP-1 inhibitor | 0.159 0.006 DBMET03612 | DBMET03612 | |
| 0.023 | 0.198 | 0.094 | Lipase inhibitor | 0.094 0.031 DBMET03613 | DBMET03613 | |
| 0.084 | 0.271 | 0.144 | Pregnane X receptor agonist | 0.144 0.065 DBMET03612 | DBMET03612 | |
| 0.01 | 0.197 | 0.031 | Histone deacetylase 11 inhibitor | 0.031 0.022 DBMET03613 | DBMET03613 | |
| 0.01 | 0.197 | 0.031 | Histone deacetylase class IV inhibitor | 0.031 0.022 DBMET03613 | DBMET03613 | |
| 0.071 | 0.261 | 0.171 | DNA methyltransferase I inhibitor | 0.171 0.086 DBMET03612 | DBMET03612 | |
| 0.015 | 0.221 | 0.055 | Prolyl endopeptidase inhibitor | 0.055 0.029 DBMET03613 | DBMET03613 | |
| 0.025 | 0.233 | 0.135 | Topoisomerase II alpha inhibitor | 0.135 0.026 DBMET03612 | DBMET03612 | |
| 0.045 | 0.256 | 0.1 | Caspase 3 inhibitor | 0.1 0.092 DBMET03613 | DBMET03613 | |
| 0.051 | 0.277 | 0.255 | Amyloid beta aggregation inhibitor | 0.255 0.056 DBMET03612 | DBMET03612 | |
| 0.026 | 0.258 | 0.052 | Factor III inhibitor | 0.052 0.03 DBMET03612 | DBMET03612 | |
| 0.027 | 0.269 | 0.112 | HIV-1 integrase inhibitor | 0.112 0.019 DBMET03612 0.069 0.05 DBMET03613 | DBMET03612 | |
| 0.005 | 0.248 | 0.036 | Leukotriene A4 hydrolase inhibitor | 0.036 0.027 DBMET03613 | DBMET03613 | |
| 0.063 | 0.319 | 0.157 | DNA methylase inhibitor | 0.157 0.111 DBMET03612 | DBMET03612 | |
| 0.006 | 0.297 | 0.03 | Histone deacetylase 2 inhibitor | 0.03 0.028 DBMET03613 | DBMET03613 | |
| 0.026 | 0.338 | 0.099 | Topoisomerase II inhibitor | 0.099 0.087 DBMET03612 | DBMET03612 | |
| 0.021 | 0.443 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.06 DBMET03613 | DBMET03613 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |